Tildrakizumab-induction therapy followed by as-needed dosing in patients with mild-to-moderate psoriasis.
Saved in:
| Title: | Tildrakizumab-induction therapy followed by as-needed dosing in patients with mild-to-moderate psoriasis. |
|---|---|
| Authors: | Aragón*, Carlota Abbad-Jaime de1 (AUTHOR), Berna-Rico*, Emilio1 (AUTHOR), Goas, Almudena2 (AUTHOR), Pérez-Bootello, Javier1 (AUTHOR), Ballester-Martinez, María Asunción1 (AUTHOR), Jaén, Pedro1 (AUTHOR), Blauvelt, Andrew3 (AUTHOR), González-Cantero, Álvaro1,2 (AUTHOR) alvarogc261893@hotmail.com |
| Source: | Clinical & Experimental Dermatology. Mar2024, Vol. 49 Issue 3, p272-273. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
